| Primary information |
|---|
| ID | antitb_1546, |
| Name | 25613372 |
| N-Terminal modification | Lassomycin |
| C-Terminal Modification | GLRRLFADQLVGRRN |
| Chemical Modification | Free |
| Linear/Cyclic | Methylation |
| Length | Free NH- group of first Glycine form NHCO bond with CO group of eight Asparagine to form cyclic bond |
| Chirality | Cyclic |
| Nature | 15 |
| Source | D |
| Origin | Cationic |
| Species | Natural |
| Strain | Derived from lentzea kentuckyensis |
| Inhibition Concentration | Mycobacterium tuberculosis |
| In Vitro/ In vivo | Mycobacterium tuberculosis H37Rv |
| Cell Line | IC50 = 0.8-3 mg/ml |
| Inhibition Concentration | in vitro |
| Sequence | 2015 |
| Cytotoxicity | NA |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other activities | NA |
| PMID | NA |
| Year of Publication | NA |
Tertiary Structure
(Technique) | Not Predicted), |
| Primary information |
|---|
| ID | antitb_1547, |
| Name | 25613372 |
| N-Terminal modification | Lassomycin |
| C-Terminal Modification | GLRRLFADQLVGRRN |
| Chemical Modification | Free |
| Linear/Cyclic | Methylation |
| Length | Free NH- group of first Glycine form NHCO bond with CO group of eight Asparagine to form cyclic bond |
| Chirality | Cyclic |
| Nature | 15 |
| Source | D |
| Origin | Cationic |
| Species | Natural |
| Strain | Derived from lentzea kentuckyensis |
| Inhibition Concentration | Mycobacterium tuberculosis |
| In Vitro/ In vivo | Mycobacterium tuberculosis MDR |
| Cell Line | IC50= 0.8-3 mg/ml |
| Inhibition Concentration | in vitro |
| Sequence | 2015 |
| Cytotoxicity | NA |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other activities | NA |
| PMID | NA |
| Year of Publication | NA |
Tertiary Structure
(Technique) | Not Predicted), |
| Primary information |
|---|
| ID | antitb_1548, |
| Name | 25613372 |
| N-Terminal modification | Lassomycin |
| C-Terminal Modification | GLRRLFADQLVGRRN |
| Chemical Modification | Free |
| Linear/Cyclic | Methylation |
| Length | Free NH- group of first Glycine form NHCO bond with CO group of eight Asparagine to form cyclic bond |
| Chirality | Cyclic |
| Nature | 15 |
| Source | D |
| Origin | Cationic |
| Species | Natural |
| Strain | Derived from lentzea kentuckyensis |
| Inhibition Concentration | Mycobacterium tuberculosis |
| In Vitro/ In vivo | Mycobacterium tuberculosis XDR |
| Cell Line | IC50= 0.8-3 mg/ml |
| Inhibition Concentration | in vitro |
| Sequence | 2015 |
| Cytotoxicity | NA |
| In vivo Model | NA |
| Lethal Dose | NA |
| Immune Responce | NA |
| Mechanism of Action | NA |
| Target | NA |
| Combination Therapy | NA |
| Other activities | NA |
| PMID | NA |
| Year of Publication | NA |
Tertiary Structure
(Technique) | Not Predicted), |